| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 112 | 184 | 132 | 137 | 48 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | -112 | -184 | -132 | -137 | -48 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | -112 | -184 | -132 | -137 | -48 | 0 | 0 | 0 | 0 | 0 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Red Shield Pharma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 23.832 | 3.340 | 3.151 | 2.956 | 2.850 | 2.796 | 2.734 | 2.743 | 2.734 | 0 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 20.313 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | 3.519 | 3.340 | 3.151 | 2.956 | 2.850 | 2.796 | 2.734 | 2.743 | 2.734 | 0 |
| Shareholders Funds | -10.839 | -10.912 | -10.860 | -10.798 | -10.637 | -10.435 | -10.204 | -10.235 | -10.204 | 0 |
| Social Capital | 49 | 49 | 48 | 47 | 46 | 45 | 44 | 45 | 44 | 44 |
| Debts | 34.670 | 14.252 | 14.011 | 13.754 | 13.487 | 13.231 | 12.938 | 12.978 | 12.939 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Red Shield Pharma S.r.l.